August 22, 2024 Economics - General 0 Comments What are the potential productivity impacts of new medications that treat Medicare beneficiaries? – Healthcare Economist One key aspect of many medications is that they not only help people feel better, but often these medications ... Read More
July 31, 2024 Adverse Event 0 Comments Methods for Including Adverse Events in Economic Evaluations – Healthcare Economist That is the title of a great review paper by Salah Ghabri, Dalia Dawoud and Michael Drummond. They discuss that guidance on the incorporation ... Read More
July 2, 2024 Broader Value Elements 0 Comments HTA and cell and gene therapy – Healthcare Economist A paper by Drummond et al. (2023) examines how health technology assessment bodies deal with the challenge of value ... Read More
June 5, 2024 Comparative Effectiveness 0 Comments Challenges in Conducting Economic Evaluations for Orphan Drugs in Rare Diseases – Healthcare Economist Why is it so hard to estimate the value of orphan drugs indicated for the treatment of rare diseases? ... Read More